Case report: Transplantation of human induced pluripotent stem cell-derived cardiomyocyte patches for ischemic cardiomyopathy
Shigeru Miyagawa(The University of Osaka), Yoshiki Sawa(Osaka Police Hospital), Tadashi Watabe(Osaka University), Köichi Toda(The University of Osaka), Yoshito Ito(Kyoto Prefectural University of Medicine), Yasushi Sakata(Osaka University), Hiroko Iseoka, Maki Takeda(The University of Osaka), Kota Suzuki(The University of Osaka), Yukako Nitta(The University of Osaka), Tomomi Shimamoto(The University of Osaka), Satoshi Kainuma(National Cerebral and Cardiovascular Center), Masao Sasai(The University of Osaka), Emiko Ito(Chiba University), Hiromi Dohi(Kyoto University), Noriko Mochizuki‐Oda, Takuji Kawamura(The University of Osaka)
Cited by 106
Related Papers
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
|Nature Medicine|2022|889
Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases
|Nature Genetics|2020|599
In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction
|Nature Medicine|1997|589
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
|Nature Medicine|1999|588
JCS/JHFS 2018 Guideline on the Diagnosis and Treatment of Cardiomyopathies
|Circulation Journal|2021|115